[PTX] YoY Annual Result on 30-Jun-2021 [#FY]

Stock
[PTX] Prescient Therapeutics Limited
Announcement Date
29-Jun-2021
Financial Year
2021
Quarter
30-Jun-2021 [#FY]
Profit Trend
YoY- -24.93%
Quarter Report
PTX's Result
PTX's Financial Summary
View:
Show?
Annual Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 3,712 2,428 1,889 1,185 1,029 1,648 940 25.69%
PBT -11,950 -9,373 -6,868 -5,334 -4,351 -5,429 -3,514 22.60%
Tax -3,712 -2,368 -1,751 -1,185 -1,029 -1,631 -940 25.69%
NP -8,238 -7,005 -5,117 -4,149 -3,321 -3,797 -2,574 21.37%
Tax Rate - - - - - - - -
Total Cost 11,950 9,433 7,007 5,334 4,351 5,445 3,514 22.60%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -221.91 -288.47 -270.85 -349.97 -322.65 -230.45 -273.87 -3.44%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 0.00%
EPS Diluted -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.